Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04053673 |
|---|---|
| Brief Title: | Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors |
| First Submitted : | August 5, 2019 |
| First Submitted that Met QC Criteria : | August 9, 2019 |
| First Posted : | August 12, 2019 |
| Last Update Submitted that Met QC Criteria : | March 27, 2023 |
| Last Update Posted : | March 28, 2023 |